Roots Analysis

FEBRUARY 21, 2022

Since the introduction of a gene sequencing method by Frederick Sanger in 1977, the field of genomic data collection and analysis has evolved significantly. Advancement in DNA sequencing technologies have resulted in noteworthy developments in various healthcare-related research fields, such as diagnostics and personalized medicine.

Marketing 52

Marketing Gene Sequencing DNA Genome 52

Drug Discovery World

APRIL 17, 2023

Genetic sequencing To assess these alterations in groups of different ancestries, Walch and colleagues analysed targeted DNA sequencing data from 4,441 patients treated for colorectal cancer at MSK between 2014 and 2022. Tumours were sequenced using MSK-IMPACT, a gene sequencing panel that looks for mutations in up to 505 genes.

Genome 52

Genome Genomics Gene Sequencing Genome Project 52

Drug Discovery World

JULY 24, 2023

Even with standardised methods, it typically takes months to achieve the first useful production of a biological drug. The post Ginkgo Bioworks awarded DARPA contract for therapeutic proteins appeared first on Drug Discovery World (DDW).

Protein 52

Protein Manufacturing Gene Sequencing Production 52

Drug Discovery World

AUGUST 5, 2022

Evonetix is reimaging biology by developing a different approach to gene synthesis. Evonetix believes this will break dependence on the service provider approach giving users the power to prepare gene sequences rapidly in their own laboratories. Why enzymatic synthesis? The work continues. “We

DNA 52

DNA Engineer Gene Sequencing Gene 52

Roots Analysis

FEBRUARY 23, 2022

Next Generation Sequencing (NGS) Library Preparation Kits. Driven by the increasing demand for gene therapies and the introduction of novel and advanced NGS techniques, the market is poised to grow at a CAGR of 18%, during the time period 2021-2035. Likely Growth of the NGS Library Preparation Kits Market. Our Social Media Platform.

Genetics 52

Genetics DNA RNA Reagent 52

pharmaphorum

MARCH 15, 2022

Gene sequencing specialist Illumina has started rolling out a new test that looks for a battery of tumour-associated genes from a single tissue sample, and could be used to help guide treatment for a broad range of cancers. The post Illumina debuts its multi-gene test for cancer in Europe appeared first on.

Gene 52

Gene Genome Genomics Gene Sequencing 52

Drug Discovery World

DECEMBER 13, 2022

“We hope that HiFi sequencing will enable us to explore variation in parts of the genome that were not previously detected, potentially enabling us to expand our understanding of causative variation in these patients.” .

Genetics 52

Genetics Research Genome Genomics 52

Drug Discovery World

FEBRUARY 5, 2024

DDW’s Megan Thomas spoke to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. Carole Nicco, CSO, BioSenic “The use of immunomodulatory drugs has always been limited by their large size, poor stability, modest ability to cross physiological barriers, rapid clearance, etc.

Research 116

Research Gene Sequencing Drug Delivery Systems Trials 116

pharmaphorum

OCTOBER 1, 2021

The debut – raising upwards of £350 million from new shares – is the largest IPO for a UK biotech company since allergy drug specialist Circassia in 2014.

Marketing 52

Marketing Business Development Genome Genomics 52

The Pharma Data

DECEMBER 28, 2020

Combining next generation sequencing (“NGS”) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. The Company has received Emergency Use Authorization (“EUA”) from the U.S.

Genetics 52

Genetics Sales Gene Sequencing Marketing 52

pharmaphorum

AUGUST 21, 2020

Cambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect mutations quicker than current approaches like gene sequencing. Longwall Ventures and Agilent have both returned to invest in the Series A, which on this occasion was led by BlueYard Capital.

DNA 59

DNA Gene Sequencing Genetics FDA Approval 59

Drug Discovery World

MARCH 27, 2023

Genomics is driving a revolution in drug development and, in the long run, the state of public healthcare. Advances in sequencing are leading to scientific breakthroughs in preventative care, faster diagnoses, and proactive medical interventions. Jack Dix , Head of Healthcare Strategy and Consulting at Kainos, expands.

Genome 52

Genome Genomics Research Scientist 52

Pharmaceutical Technology

MAY 26, 2023

Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines. As per the company, dbDNA is suitable for rapid, scalable manufacture of GMP DNA and can incorporate gene sequences of sizes ranging from 500bp to 20kb, which are typically unstable as pDNA.

DNA 130

DNA Manufacturing Gene Therapy Gene 130